Overview

Trayer is a biotechnology company focused on the development of live biotherapeutic (LBP) medicines. Our team leverages the growing advances in the field of microbiome science to deliver novel therapies for patients with unmet needs. Our lead program SA-412 is currently under development for the treatment of PKU.